The Omicron variant has numerous mutations in the spike protein (S-gene) [33], and drugs used in severe COVID-19 cases such as corticosteroids and interleukin-6 receptor blockers may not effectively target the spike protein in severe Omicron. This evidence concerns the gene IL6R and COVID-19.